An Open-label Study of Tiagabine as Augmentation Therapy for Anxiety

Thomas L. Schwartz Department of Psychiatry, Suny Upstate Medical University, Syracuse, NY, USACorrespondence[email protected]

Nouman Azhar Department of Psychiatry, Suny Upstate Medical University, Syracuse, NY, USA

Juhi Husain Department of Psychiatry, Suny Upstate Medical University, Syracuse, NY, USA

Nikhil Nihalani Department of Psychiatry, Suny Upstate Medical University, Syracuse, NY, USA

Mihai Simionescu Department of Psychiatry, Suny Upstate Medical University, Syracuse, NY, USA

Douglas Coovert Department of Psychiatry, Suny Upstate Medical University, Syracuse, NY, USA

Shefali Jindal Department of Psychiatry, Suny Upstate Medical University, Syracuse, NY, USA

Syed Tirmazi Department of Psychiatry, Suny Upstate Medical University, Syracuse, NY, USA

show all

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Massimiliano Buoli, Alice Caldiroli, Elisabetta Caletti, Riccardo Augusto Paoli & Alfredo Carlo Altamura. (2013) New approaches to the pharmacological management of generalized anxiety disorder. Expert Opinion on Pharmacotherapy 14:2, pages 175-184.
Read now

Panagiotis Oulis, Vasilios G. Masdrakis, Evangelos Karapoulios, Nikolaos A. Karakatsanis, Anastasios V. Kouzoupis, George Konstantakopoulos & Constantin R. Soldatos. (2009) Tiagabine augmentation to fluvoxamine–risperidone combination in the treatment of obsessive-compulsive disorder. The World Journal of Biological Psychiatry 10:4-3, pages 953-955.
Read now

Thomas L Schwartz & Nikhil Nihalani. (2006) Tiagabine in anxiety disorders. Expert Opinion on Pharmacotherapy 7:14, pages 1977-1987.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

An Open-label Study of Tiagabine as Augmentation Therapy for Anxiety

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

An Open-label Study of Tiagabine as Augmentation Therapy for Anxiety

Citations (3)

Read on this site (3)

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date